Detalles de la búsqueda
1.
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
Oncology
; 101(1): 22-31, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195058
2.
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.
Int J Clin Oncol
; 28(8): 1073-1081, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209158
3.
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
BMC Cancer
; 22(1): 19, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980029
4.
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Jpn J Clin Oncol
; 52(12): 1416-1422, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047806
5.
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
Int J Clin Oncol
; 26(5): 941-950, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33483857
6.
Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.
Oncologist
; 25(11): e1614-e1620, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32490554
7.
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909.
Esophagus
; 17(4): 417-424, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342253
8.
Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
Gastric Cancer
; 21(6): 1050-1057, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658055
9.
Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
Oncology
; 92(4): 205-212, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28142137
10.
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
Oncology
; 93(5): 329-335, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28866662
11.
Association between ABCG2 and SLCO1B1 polymorphisms and adverse drug reactions to regorafenib: a preliminary studyâ©.
Int J Clin Pharmacol Ther
; 55(5): 409-415, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28157071
12.
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.
Jpn J Clin Oncol
; 46(3): 228-33, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26759349
13.
Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Int J Clin Oncol
; 21(5): 890-898, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26980212
14.
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.
Int J Clin Oncol
; 26(5): 951-953, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33656656
15.
A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.
BMC Cancer
; 15: 601, 2015 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26311588
16.
Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
Int J Clin Oncol
; 20(4): 755-60, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424249
17.
[A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy].
Gan To Kagaku Ryoho
; 42(4): 457-61, 2015 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-25963692
18.
Long-term outcomes and prognostic factors of patients with advanced gastric cancer treated with S-1 plus cisplatin combination chemotherapy as a first-line treatment.
Int J Clin Oncol
; 19(4): 656-61, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23999902
19.
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer.
Sci Rep
; 14(1): 12422, 2024 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38816500
20.
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.
Target Oncol
; 18(5): 707-715, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668815